R. Hori et al., ROLE OF P-GLYCOPROTEIN IN RENAL TUBULAR SECRETION OF DIGOXIN IN THE ISOLATED-PERFUSED RAT-KIDNEY, The Journal of pharmacology and experimental therapeutics, 266(3), 1993, pp. 1620-1625
The mechanism for renal tubular secretion of digoxin as well as its in
teraction with quinidine or verapamil were investigated using the isol
ated perfused rat kidney. [H-3]Digoxin was instantaneously administere
d into the renal artery together with [C-14]inulin and Evans blue-albu
min, and renal venous and urinary outflow curves were measured. The ra
tio of fractional excretion to filtration fraction for digoxin was 2.4
0 +/- 0.40, indicating involvement of tubular secretion. Quinidine and
verapamil decreased the ratio of fractional excretion to filtration f
raction in a concentration-dependent manner, and this inhibition was i
ndicated to occur at transport from cells to lumen across luminal memb
ranes. Neither tetraethylammonium nor p-aminohippurate affected the re
nal handling of digoxin. Because ouabain and digitoxose showed no infl
uence on the value of fractional excretion to filtration fractions, Na
+,K+-ATPase is not involved in the tubular secretion of digoxin. A met
abolic inhibitor, 2,4-dinitrophenol, markedly inhibited digoxin secret
ion. Agents that bind to P-glycoprotein, such as vinblastine, daunorub
icin and reserpine, markedly inhibited the secretion of digoxin. Recen
tly, we have found that digoxin is a substrate transported by P-glycop
rotein. The findings obtained here support the hypothesis that digoxin
is secreted by P-glycoprotein located on the luminal membrane of rena
l tubular epithelial cells, and that clinically important interactions
with quinidine and verapamil are caused by the inhibition of P-glycop
rotein.